Alesco Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,228
| Closed | -$22K | – | 122 |
|
|
2017
Q2 | $22K | Hold |
2,228
| – | – | ﹤0.01% | 114 |
|
|
2017
Q1 | $54K | Hold |
2,228
| – | – | ﹤0.01% | 112 |
|
|
2016
Q4 | $72K | Hold |
2,228
| – | – | 0.01% | 108 |
|
|
2016
Q3 | $111K | Hold |
2,228
| – | – | 0.01% | 110 |
|
|
2016
Q2 | $94K | Hold |
2,228
| – | – | 0.01% | 106 |
|
|
2016
Q1 | $147K | Hold |
2,228
| – | – | 0.01% | 104 |
|
|
2015
Q4 | $139K | Hold |
2,228
| – | – | 0.01% | 106 |
|
|
2015
Q3 | $149K | Hold |
2,228
| – | – | 0.01% | 103 |
|
|
2015
Q2 | $217K | Hold |
2,228
| – | – | 0.02% | 104 |
|
|
2015
Q1 | $208K | Hold |
2,228
| – | – | 0.02% | 98 |
|
|
2014
Q4 | $198K | Hold |
2,228
| – | – | 0.02% | 98 |
|
|
2014
Q3 | $154K | Hold |
2,228
| – | – | 0.02% | 94 |
|
|
2014
Q2 | $128K | Sell |
2,228
-814
| -27% | -$46.8K | 0.01% | 92 |
|
|
2014
Q1 | $121K | Hold |
3,042
| – | – | 0.01% | 88 |
|
|
2013
Q4 | $128K | Buy |
+3,042
| New | +$128K | 0.01% | 82 |
|